These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 880637)

  • 1. [Change of the reactibility of the myocardium following the termination of the beta-blocking effect of trimepranol and practolol].
    Svec P; Inczinger F; Béderová E; Zigová L
    Cesk Farm; 1977 May; 26(4):128-30. PubMed ID: 880637
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The nature of differences in beta-adrenergic receptors].
    Abrmets II; Simon IB
    Biull Eksp Biol Med; 1975 May; 79(5):11-4. PubMed ID: 1227580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents.
    Adam KR; Baird JR; Burges RA; Linnell J
    Eur J Pharmacol; 1974 Feb; 25(2):170-5. PubMed ID: 4154851
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of practolol and butoxamine on aortic arch malformation in beta adrenoreceptor stimulated chick embryos.
    Gilbert EF; Bruyere HJ; Ishikawa S; Cheung MO; Hodach RJ
    Teratology; 1977 Jun; 15(3):317-23. PubMed ID: 196355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of trimepranol and practolol on the heart damaged by isoprenaline].
    Svec P; Seginko J; Inczinger F
    Cesk Farm; 1976 Oct; 25(8):312-5. PubMed ID: 1009588
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative morphologic studies on the myocardium in early stages of ontogenesis and after application of various cardioactive agents].
    Bózner A; Veselá A; Dostál J
    Gegenbaurs Morphol Jahrb; 1980; 126(3):307-13. PubMed ID: 6108899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some adrenergic beta-blocking agents affecting lipolysis in human adipose tissue in vitro.
    Wenkeová J; Kuhn E; Wenke M
    Eur J Pharmacol; 1976 May; 37(1):91-5. PubMed ID: 6293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of selective beta-adrenoceptor blockade in man.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1973 Sep; 49(1):106-14. PubMed ID: 4150760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reaction of peripheral veins and arteries following administration of beta-active agents. Studies on isoproterenol, propranolol, and practolol].
    Bischoff K; Larsen N; Mucha C; Westermann KW
    Med Klin; 1976 Jul; 71(30):1239-43. PubMed ID: 940512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
    Robak J; Grodzińska L
    Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between aminophylline and beta adrenergic blockers "propranolol" & "practolol" on the myocardium and tracheal spirals in experimental animals.
    el-Gawhary NE; Ghaleb HA; Goda NA; el-Messiry SA; Moussa NM
    J Egypt Med Assoc; 1979; 62(1-2):171-83. PubMed ID: 262469
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cardioselective beta-blockade by metoprolol on the phasic myocardial blood content and epi/endocardial ratio.
    Virtanen K; Frick MH
    Ann Clin Res; 1977 Apr; 9(2):97-9. PubMed ID: 883763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local anaesthetic and myocardial depressant effects of beta adrenoceptor blocking agents.
    Singh KP
    Indian J Physiol Pharmacol; 1980; 24(2):161-2. PubMed ID: 6103869
    [No Abstract]   [Full Text] [Related]  

  • 20. A survey of the pharmacological properties of metoprolol in animals and man.
    Ablad B; Borg KO; Carlsson E; EK L; Johnson G; Malmfors T; Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):7-23. PubMed ID: 1094804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.